Center for Lung Biology, University of Washington, 815 Mercer Street, Seattle, WA 98109, USA.
Am J Pathol. 2010 Jan;176(1):64-73. doi: 10.2353/ajpath.2010.090158. Epub 2009 Dec 11.
Tissue inhibitor of metalloproteinases 3 (TIMP3) inhibits not only matrix metalloproteinases but also a disintegrin and metalloproteinase domain family members and thus contributes to controlling diverse processes mediated by proteolysis. We used Timp3(-/-) mice to assess the role of this inhibitor in acute lung injury. After bleomycin-induced injury, inflammation, as indicated by the influx of neutrophils in bronchoalveolar lavage (BAL), peaked at 7 days post-injury in the wild-type mice and began to wane thereafter; however, in Timp3(-/-) mice, inflammation persisted up to 28 days. Furthermore, although the level of chemokines in BAL and lung homogenate was similar in both genotypes, BAL from Timp3(-/-) mice 7, 14, and 28 days post-injury had increased neutrophil chemotactic activity compared with wild-type BAL. At day 14, a higher percentage of apoptotic neutrophils were present in wild-type mice compared with Timp3(-/-) mice, further suggesting that TIMP3 constrains continued neutrophil influx. In addition, total matrix metalloproteinase activity was increased in lungs from Timp3(-/-) mice, and treatment of mice with a synthetic inhibitor of metalloproteinases rescued the enhanced neutrophilia phenotype. These data demonstrate that TIMP3 regulates neutrophil influx in the lung following injury through its ability to inhibit metalloproteinase activity and indicates that TIMP3 functions to promote the resolution of inflammation in the lung.
金属蛋白酶组织抑制剂 3(TIMP3)不仅抑制基质金属蛋白酶,还抑制解整合素金属蛋白酶家族成员,从而有助于控制多种由蛋白水解介导的过程。我们使用 Timp3(-/-)小鼠来评估这种抑制剂在急性肺损伤中的作用。在博来霉素诱导的损伤后,炎症,如支气管肺泡灌洗液(BAL)中中性粒细胞的流入所表明的那样,在野生型小鼠中于损伤后 7 天达到峰值,此后开始减少;然而,在 Timp3(-/-)小鼠中,炎症持续到 28 天。此外,尽管两种基因型 BAL 和肺匀浆中的趋化因子水平相似,但 Timp3(-/-)小鼠 BAL 在损伤后 7、14 和 28 天具有增加的中性粒细胞趋化活性,与野生型 BAL 相比。在第 14 天,与 Timp3(-/-)小鼠相比,野生型小鼠中凋亡的中性粒细胞比例更高,这进一步表明 TIMP3 限制了持续的中性粒细胞内流。此外,Timp3(-/-)小鼠肺中的总基质金属蛋白酶活性增加,用金属蛋白酶合成抑制剂治疗可挽救增强的中性粒细胞增多表型。这些数据表明,TIMP3 通过抑制金属蛋白酶活性来调节损伤后肺中中性粒细胞的流入,并表明 TIMP3 可促进肺中炎症的消退。